1. Home
  2. AMCR vs GH Comparison

AMCR vs GH Comparison

Compare AMCR & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amcor plc

AMCR

Amcor plc

N/A

Current Price

$44.47

Market Cap

20.7B

ML Signal

N/A

Logo Guardant Health Inc.

GH

Guardant Health Inc.

N/A

Current Price

$154.83

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCR
GH
Founded
1926
2011
Country
Switzerland
United States
Employees
50000
N/A
Industry
Miscellaneous manufacturing industries
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
22.9B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
AMCR
GH
Price
$44.47
$154.83
Analyst Decision
Buy
Strong Buy
Analyst Count
13
26
Target Price
$50.98
★ $200.76
AVG Volume (30 Days)
★ 3.7M
2.1M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 5.84%
N/A
EPS Growth
★ 643.75
6.74
EPS
★ 0.52
N/A
Revenue
★ $13,640,000,000.00
$982,021,000.00
Revenue This Year
$2.18
$39.22
Revenue Next Year
$2.35
$35.02
P/E Ratio
$86.86
★ N/A
Revenue Growth
9.40
★ 32.88
52 Week Low
$8.09
$74.55
52 Week High
$50.94
$191.05

Technical Indicators

Market Signals
Indicator
AMCR
GH
Relative Strength Index (RSI) 47.63 40.52
Support Level $41.19 $154.16
Resistance Level $45.22 $177.55
Average True Range (ATR) 1.13 10.36
MACD -0.28 -2.14
Stochastic Oscillator 11.68 36.10

Price Performance

Historical Comparison
AMCR
GH

About AMCR Amcor plc

Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. Since the Berry acquisition in 2025, about 60% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which includes beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: